Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Olema Oncology to Present Preclinical Data for OP-3136, a Potent KAT6 Inhibitor, Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at the 2025 AACR Annual Meeting
-
Evaxion to present new phase 2 data for AI-designed personalized cancer vaccine EVX-01 at AACR Annual Meeting
-
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
-
NeOnc Technologies Holdings Announces Effectiveness of Registration Statement and Anticipated Listing Date of Common Stock on Nasdaq Global Market
-
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025
-
Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Deve
-
Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline with Five Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
-
Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend
-
Media Advisory — Newport News Shipbuilding Apprentice School to Host Commencement Ceremony for 2024 Graduates
-
Nurix Therapeutics Announces Multiple Presentations at the American Association for Cancer Research (AACR) 2025 Annual Meeting
-
Affimed Announces Acceptance of AFM24 Abstract on Dose Optimization for Presentation at American Association for Cancer Research Annual Meeting
-
Quanta Therapeutics Announces Late-Breaking Presentation of QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025
-
Pyxis Oncology to Present New Preclinical Data Supporting Development of First-In-Concept ADC Targeting EDB+FN in Tumor Microenvironment at AACR 2025
-
ECD Auto Design Reports Third Quarter 2024 Financial Results; Revenues Increase 30% to $6.4 Million
-
CLEAR and American Express Renew Partnership to Provide Premium Travel Experiences at Airports to Card Members
-
Farmers & Merchants Bancorp, Inc. Declares 2025 First-Quarter Cash Dividend
-
Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual M
-
Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
-
Tempest Announces Amezalpat Poster Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
-
ORIC® Pharmaceuticals Announces ORIC-944 Preclinical Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
-
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
-
Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Deve
-
Nokia Corporation: Repurchase of own shares on 25.03.2025
-
Global Water Announces Proposed Public Offering of Common Stock
-
WeRide Inc. Files Its 2024 Annual Report on Form 20-F
-
Draganfly to Host Shareholder Update Call on March 27, 2025
-
Lendmark Financial Services Opens its 54th Georgia Branch in Vidalia, Marking its Eighth Portfolio Branch Opening in 2025
-
Worthington Enterprises Reports Third Quarter Fiscal 2025 Results
-
ARMOUR Residential REIT, Inc. Announces Guidance for April 2025 Dividend Rate Per Common Share
-
Stryker announces Annual Meeting of Shareholders
-
Treace Highlights New Innovations at the 2025 ACFAS Annual Scientific Conference
-
Artesian Resources Corporation Reports 2024 Year-End Earnings and Fourth Quarter Results
-
Americold Announces Pricing Terms for $400,000,000 Notes Offering
-
GameStop Announces Update to its Investment Policy to Add Bitcoin as a Treasury Reserve Asset
-
National Association of Federal Retirees Calls for Action on Seniors' Issues in Federal Election
-
Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates
-
Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
-
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
-
Reed’s Reports Fourth Quarter and Full Year 2024 Results
-
Elutia Advances Scientific Leadership with Publication of New Study on Antibiotic-Eluting Biologic Envelope
-
Evolution Petroleum Announces Upcoming Investor Events
-
Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th
-
dLocal Announces CFO Transition due to Health Reasons
-
Nortech Systems Incorporated to Report Fourth Quarter 2024 Financial Results and Hold a Conference Call on March 31, 2025
-
Glass House Brands Reports Record Setting Fourth Quarter 2024 Financial Results
-
Amplify Provides Additional Information on Acquisition of Assets from Juniper Capital
-
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date March 14, 2025
-
Brilliant Earth Announces Participation in JP Morgan Retail Round Up
-
OrthoPediatrics Corp. to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference


